Moreover, miR-26a alleviated the inhibitory effect of AP-2α and the miR-26a inhibitor on glioma cells by upregulating the expression of Nanog/Sox2 and the IL6/Jak2/STAT3 signaling pathway (Figure 8D). This evidence concerns the gene STAT3 and central nervous system cancer.